全球人工器官市場規模：依器官類型、競爭狀況、區域狀況、預測

Global Artificial Organs Market Size By Organ Type (Artificial Heart, Artificial Kidney), By Competitive Landscape, By Geographic Scope And Forecast

出版日期: 2025年04月29日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

人造器官市場規模及預測

2024 年人造器官市場規模價值為 209.3 億美元，預計到 2032 年將達到 355.6 億美元，2026 年至 2032 年的複合年成長率為 7.56%。

人造器官市場的擴張得益於生物人工器官製造、標準化和自動化等生產方法技術的不斷進步。本研究報告對全球人造器官市場進行了全面評估，深入分析了關鍵細分市場、趨勢、促進因素、限制因素、競爭格局以及其他重要因素。

定義全球人造器官市場

人工器官是植入或整合到體內，用於複製或增強器官自然功能的醫療設備。人工器官主要包括可植入裝置，例如全人工心臟和心律調節器，以及器官支持裝置，例如透析設備和體外膜氧合 (ECMO) 機。人工器官通常由單一人體幹細胞形成，然後在實驗室中培養。人工器官主要由已與接受者自身幹細胞一起培養的塑膠製成，因此人體免疫系統不會排斥該人工器官。

全球人造器官市場概況

生產流程技術的不斷發展，包括生物人工器官的製造、標準化和自動化，是市場擴張的主要驅動力。由於糖尿病、心臟病和慢性腎臟病等嚴重的健康問題，器官衰竭在老年人中變得越來越普遍。此外，車禍造成的受傷和截肢也越來越頻繁，增加了對替代器官的需求。

隨著醫療技術的進步以及社會對升級現有醫療基礎設施的意識不斷增強，先進的人工輔助系統也應運而生。 3D生物列印技術的發展以及融入人工智慧（AI）的人工設備的製造也改善了市場前景。另一方面，人工器官市場的成長受到移植價格上漲的限制。然而，器官捐贈者的短缺以及在需要時難以找到捐贈者的問題，正在推動全球人工器官技術的發展。

The expansion of the Artificial Organs Market is being driven by rising technological advancements in production methods including bioartificial organ manufacturing, standardization, and automation. The market is comprehensively evaluated in the study on the global Artificial Organs Market. The research provides a thorough analysis of the market's key segments, trends, drivers, restraints, competitive environment, and other important elements.

Global Artificial Organs Market Definition

Artificial organs are medical devices that are implanted or integrated into the body to replicate or enhance the natural functioning of an organ. Artificial organs primarily include implantable devices such as entirely artificial hearts and pacemakers and organ support devices such as dialysis machines and extracorporeal membrane oxygenation (ECMO) devices. Artificial organs are usually formed from individual human stem cells and later cultured in the laboratory. They are mainly composed of plastics in stem cells from transplant recipients who have colonized them. Therefore, the body's immune system does not reject artificial organs.

Global Artificial Organs Market Overview

Growing technological developments in production processes like the creation of bioartificial organs, standardization, and automation are the main reasons fueling the market's expansion. Organ failure is becoming more common among the elderly as a result of significant health issues such as diabetes, heart disease, and chronic renal disease. The need for replacement organs is also growing as injuries from auto accidents and amputations happen more frequently.

Advanced artificial support systems have also been created as a result of improvements in medical technology and increased public awareness of the need to upgrade current medical infrastructure. The development of 3D bioprinting and the production of artificial gadgets by incorporating artificial intelligence (AI) has also improved market prospects. On the other side, the market expansion for artificial organs is constrained by high transplant prices. However, the lack of organ donors and the difficulty in finding them when needed is what is propelling the global development of artificial organ technology.

Global Artificial Organs Market Segmentation Analysis

The Global Artificial Organs Market is segmented based on Organ Type and Geography.

Artificial Organs Market, By Organ Type

Artificial Heart
Artificial Kidney
ArtificialPancreas
Artificial Lungs
Artificial Cochlear Implants
Others

Based on Organ Type, the market is segmented into Artificial Heart, Artificial Kidney, Artificial Pancreas, Artificial Lungs, Artificial Cochlear Implants, and Others. Due to the rising mortality rate associated with dialysis and the rising demand for artificial kidneys, which is the factor driving the global growth of the Artificial Organs Market, the Artificial Kidney sector commands a sizable market share.

Artificial Organs Market, By Geography

North America
Europe
Asia Pacific
Rest of the world

Based on Geography, the Global Artificial Organs Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region holds a large number of shares in the market because of the increasing number of chronic diseases, the growing organ transplant acceptance, and the increase in the adoption of advanced technology in the region, which is the factor that boosts the market growth of the Artificial Organs Market.

Key Players

The "Global Artificial Organs Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Boston Scientific Corporation, Berlin Heart GmbH, Baxter International Inc., Edward Lifesciences Corporation, Carmat SA, B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd, Abiomed, Getinge AB, and Medtronic PLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

1 INTRODUCTION OF GLOBAL ARTIFICIAL ORGANS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ARTIFICIAL ORGANS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL ARTIFICIAL ORGANS MARKET, BY ORGAN TYPE

5.1 Overview
5.2 Artificial Heart
5.3 Artificial Kidney
5.4 Artificial Pancreas
5.5 Artificial Lungs
5.6 Cochlear Implants
5.7 Others

6 GLOBAL ARTIFICIAL ORGANS MARKET, BY GEOGRAPHY

6.1 Overview
6.2 North America
- 6.2.1 U.S.
- 6.2.2 Canada
- 6.2.3 Mexico
6.3 Europe
- 6.3.1 Germany
- 6.3.2 U.K.
- 6.3.3 France
- 6.3.4 Rest of Europe
6.4 Asia Pacific
- 6.4.1 China
- 6.4.2 Japan
- 6.4.3 India
- 6.4.4 Rest of Asia Pacific
6.5 Rest of the World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa

7 GLOBAL ARTIFICIAL ORGANS MARKET COMPETITIVE LANDSCAPE

7.1 Overview
7.2 Company Market Ranking
7.3 Key Development Strategies

8 COMPANY PROFILES

8.1 Boston Scientific Corporation
- 8.1.1 Overview
- 8.1.2 Financial Performance
- 8.1.3 Product Outlook
- 8.1.4 Key Developments
8.2 Berlin Heart GmbH
- 8.2.1 Overview
- 8.2.2 Financial Performance
- 8.2.3 Product Outlook
- 8.2.4 Key Developments
8.3 Baxter International Inc.
- 8.3.1 Overview
- 8.3.2 Financial Performance
- 8.3.3 Product Outlook
- 8.3.4 Key Developments
8.4 Edward Lifesciences Corporation
- 8.4.1 Overview
- 8.4.2 Financial Performance
- 8.4.3 Product Outlook
- 8.4.4 Key Developments
8.5 Carmat SA
- 8.5.1 Overview
- 8.5.2 Financial Performance
- 8.5.3 Product Outlook
- 8.5.4 Key Developments
8.6 B. Braun Melsungen AG
- 8.6.1 Overview
- 8.6.2 Financial Performance
- 8.6.3 Product Outlook
- 8.6.4 Key Developments
8.7 Asahi Kasei Medical Co. Ltd
- 8.7.1 Overview
- 8.7.2 Financial Performance
- 8.7.3 Product Outlook
- 8.7.4 Key Developments
8.8 Abiomed
- 8.8.1 Overview
- 8.8.2 Financial Performance
- 8.8.3 Product Outlook
- 8.8.4 Key Developments
8.9 Getinge AB
- 8.9.1 Overview
- 8.9.2 Financial Performance
- 8.9.3 Product Outlook
- 8.9.4 Key Developments
8.10 Medtronic PLC
- 8.10.1 Overview
- 8.10.2 Financial Performance
- 8.10.3 Product Outlook
- 8.10.4 Key Developments